{
    "clinical_study": {
        "@rank": "67228", 
        "acronym": "ElastoMAP", 
        "arm_group": {
            "arm_group_label": "The study population", 
            "description": "The study population consists of pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both single or multiple pregnancies can be included).\nIntervention : Cervical ultrasound +elastography 1 Intervention : Vaginal fibronectin measurement Intervention : Tocolytic treatment for 2 hours Intervention : Cervical ultrasound +elastography 2"
        }, 
        "brief_summary": {
            "textblock": "The hypothesis tested is that the physical changes associated with cervical ripening result\n      in a detectable decrease in rigidity. The main objective of this study is therefore to\n      determine whether the measured elastographic rigidity of cervical tissues in addition to\n      cervix size can be used to predict delivery within the next 48 hours (creation of a\n      prognostic score)."
        }, 
        "brief_title": "The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obstetric Labor", 
            "Labor Onset", 
            "Obstetric Labor, Premature"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obstetric Labor, Premature", 
                "Premature Birth"
            ]
        }, 
        "detailed_description": {
            "textblock": "The secondary objectives of this study are:\n\n      A-To compare the prognostic qualities of elastography scores and fetal fibronectin\n      measurements for predicting the risk of delivery in the next 48 hours.\n\n      B-To evaluate the economic impact of introducing elastographic and fibronectin measures\n      during consultatios for obstetric emergencies from the point of vue of the French social\n      security system and the hospital.\n\n      C-To evaluate the prognostic value of elastographic measurements in the subgroup twins.\n\n      D-To study elastography variation according to patient outcomes.\n\n      E-Evaluate the reproducibility of intra-and inter-rater elastographic measurements."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must have given her informed and signed consent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n          -  Pregnant women presenting between the 24th and 34th week of pregnancy, with uterine\n             contractions associated with cervical changes objectified by ultrasound examination\n             of the cervix (5-25mm)\n\n          -  Single or multiple pregnancy\n\n        Exclusion Criteria:\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection, under tutorship or curatorship\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient has lost her water (placental rupture)\n\n          -  History of cervical surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population consists of pregnant women presenting between the 24th and 34th week\n        of pregnancy, with uterine contractions associated with cervical changes objectified by\n        ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both\n        single or multiple pregnancies can be included)."
            }
        }, 
        "enrollment": {
            "#text": "204", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02021539", 
            "org_study_id": "LOCAL/2013/VL-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "The study population", 
                "description": "Included patients will have a cervical ultrasound upon arrival in the maternity ward.  This latter exam will include elastographic measurements, and will be followed by a vaginal fibronectin measurement. Patients will then be treated via a tocolytic (anti-contraction treatment), and two hours later a second cervial ultrasound including elastographic measures will be performed.", 
                "intervention_name": "Cervical ultrasound +elastography 1", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "The study population", 
                "description": "Included patients will have a cervical ultrasound upon arrival in the maternity ward.  This latter exam will include elastographic measurements, and will be followed by a vaginal fibronectin measurement. Patients will then be treated via a tocolytic (anti-contraction treatment), and two hours later a second cervial ultrasound including elastographic measures will be performed.", 
                "intervention_name": "Vaginal fibronectin measurement", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "The study population", 
                "description": "Included patients will have a cervical ultrasound upon arrival in the maternity ward.  This latter exam will include elastographic measurements, and will be followed by a vaginal fibronectin measurement. Patients will then be treated via a tocolytic (anti-contraction treatment), and two hours later a second cervial ultrasound including elastographic measures will be performed.", 
                "intervention_name": "Tocolytic treatment for 2 hours", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "The study population", 
                "description": "Included patients will have a cervical ultrasound upon arrival in the maternity ward.  This latter exam will include elastographic measurements, and will be followed by a vaginal fibronectin measurement. Patients will then be treated via a tocolytic (anti-contraction treatment), and two hours later a second cervial ultrasound including elastographic measures will be performed.", 
                "intervention_name": "Cervical ultrasound +elastography 2", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tocolytic Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elastography of the cervix", 
            "Cervical elastography", 
            "Predicting delivery"
        ], 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "N\u00eemes Cedex 9", 
                    "country": "France", 
                    "zip": "30029"
                }, 
                "name": "CHRU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
            }, 
            "investigator": [
                {
                    "last_name": "Vincent Letouzey, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Eve Mousty, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fr\u00e9d\u00e9ric Grosjean, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Pierre Mar\u00e8s, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Renaud de Tayrac, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Florent Masia, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Arnaud Cornille, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "St\u00e9phanie Huberlant, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery", 
        "other_outcome": [
            {
                "measure": "Patient age", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "measure": "Body mass index", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "measure": "Number of previous vaginal deliveries", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "measure": "Pregnancy term", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "measure": "Prescribed treatment (rest, hospitalization, medications)", 
                "safety_issue": "No", 
                "time_frame": "baseline (day 0)"
            }, 
            {
                "measure": "Delay between first cervical ultrasound upon patient arrival and first ultrasound with elastography", 
                "safety_issue": "No", 
                "time_frame": "Day 0 or 1"
            }
        ], 
        "overall_contact": {
            "email": "vincent.letouzey@chu-nimes.fr", 
            "last_name": "Vincent Letouzey, MD", 
            "phone": "+33.(0)4.66.68.32.16"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
            "last_name": "Vincent Letouzey, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Ultrasound measure of the cervix (mm)", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "measure": "Ultrasound measure of the cervix (mm)", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "The score ranges from 0 to 10.", 
                "measure": "Elastography score", 
                "safety_issue": "No", 
                "time_frame": "Day 0 or within 12 hours"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02021539"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Score ranges from 0 to 10", 
                "measure": "Elastography score", 
                "safety_issue": "No", 
                "time_frame": "after 2 hours of tocolytic treatment on day 0"
            }, 
            {
                "measure": "Vaginal fetal fibronectin", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "measure": "Vaginal fetal fibronectin", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "measure": "Avoidable hospital costs", 
                "safety_issue": "No", 
                "time_frame": "Hospital discharge (expected maximum of 20 days)"
            }, 
            {
                "measure": "Was the first ultrasound/elastography carried out while the patient was already on tocolytics? yes/no", 
                "safety_issue": "No", 
                "time_frame": "Day 0 or 1"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}